KANARB Trademark

Trademark Overview

On Tuesday, September 14, 2010, a trademark application was filed for KANARB with the United States Patent and Trademark Office. The USPTO has given the KANARB trademark a serial number of 79088197. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, May 27, 2022. This trademark is owned by BORYUNG PHARMACEUTICAL CO., LTD. The KANARB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for hypertension prevention, pharmaceuticals for hypertension treatment, pharmaceuticals for antihypertension purposes; capsules for medicines, namely, gelatin capsules sold empty for pharmaceuticals; drugs for medical purposes, namely, antihypertensive medicines; chemical preparations for medical purposes, namely, antihypertensive medicines; pharmaceutical preparations, namely, antihypertensive preparations; diagnostic preparations for medical purposes; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; antihypertensive pharmaceutical preparations
kanarb

General Information

Serial Number79088197
Word MarkKANARB
Filing DateTuesday, September 14, 2010
Status709 - CANCELLED - SECTION 71
Status DateFriday, May 27, 2022
Registration Number4054573
Registration DateTuesday, November 15, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2011

Trademark Statements

Goods and ServicesPharmaceuticals for hypertension prevention, pharmaceuticals for hypertension treatment, pharmaceuticals for antihypertension purposes; capsules for medicines, namely, gelatin capsules sold empty for pharmaceuticals; drugs for medical purposes, namely, antihypertensive medicines; chemical preparations for medical purposes, namely, antihypertensive medicines; pharmaceutical preparations, namely, antihypertensive preparations; diagnostic preparations for medical purposes; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; antihypertensive pharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 27, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoryung Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR
Party NameBORYUNG PHARMACEUTICAL CO., LTD
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR
Party NameBORYUNG PHARMACEUTICAL CO., LTD
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events

Event DateEvent Description
Tuesday, April 4, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, March 16, 2023GENERIC MADRID TRANSACTION SENT TO IB
Thursday, March 16, 2023GENERIC MADRID TRANSACTION CREATED
Saturday, March 11, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, January 27, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 27, 2022CANCELLED SECTION 71
Sunday, November 15, 2020COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, October 1, 2020INTERNATIONAL REGISTRATION RENEWED
Sunday, June 30, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 30, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 30, 2017NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Thursday, November 30, 2017REGISTERED-SEC.71 ACCEPTED
Wednesday, November 29, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 26, 2017TEAS SECTION 71 RECEIVED
Thursday, May 25, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, November 15, 2016COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, March 18, 2013NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 6, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, June 20, 2012FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, June 20, 2012FINAL DISPOSITION PROCESSED
Wednesday, February 15, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 15, 2011REGISTERED-PRINCIPAL REGISTER
Sunday, October 23, 2011NOTIFICATION PROCESSED BY IB
Tuesday, August 30, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2011PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 10, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Friday, July 22, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 22, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 20, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 20, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 11, 2011ASSIGNED TO LIE
Thursday, June 23, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 21, 2011REFUSAL PROCESSED BY IB
Monday, January 3, 2011NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, January 3, 2011REFUSAL PROCESSED BY MPU
Wednesday, December 29, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 28, 2010NON-FINAL ACTION WRITTEN
Wednesday, December 22, 2010ASSIGNED TO EXAMINER
Friday, November 12, 2010APPLICATION FILING RECEIPT MAILED
Monday, November 8, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 5, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

kanarb preparations pharmaceuticals purposes namely antihypertensive medical pharmaceutical medicines hypertension treatment